Composition of the immunoglobulin G glycome associates with the severity of COVID-19
Petrovic, T.; Alves, I.; Bugada, D.; Pascual, J.; Vuckovic, F.; Skelin, A.; Gaifem, J.; Villar, J.; Vicente, M. M.; Fernandes, A.; Dias, A. M.; Kurolt, I.-C.; Markotic, A.; Primorac, D.; Soares, A.; Malheiro, L.; Trbojevic-Akmacic, I.; Abreu, M.; Sarmento e Castro, R.; Bettinelli, S.; Callegaro, A.; Arosio, M.; Sangiorgio, L.; Lorini, L.; Castells, X.; Horcajada, J. P.; Pinho, S.; Allegri, M.; Barrios, C.; Lauc, G.
Show abstract
A large variation in the severity of disease symptoms is one of the key open questions in COVID-19 pandemics. The fact that only a small subset of people infected with SARS-CoV-2 develop severe disease suggests that there have to be some predisposing factors, but biomarkers that reliably predict disease severity have not been found so far. Since overactivation of the immune system is implicated in a severe form of COVID-19 and the IgG glycosylation is known to be involved in the regulation of different immune processes, we evaluated the association of inter-individual variation in IgG N-glycome composition with the severity of COVID-19. The analysis of 166 severe and 167 mild cases from hospitals in Spain, Italy and Portugal revealed statistically significant differences in the composition of the IgG N-glycome. The most notable difference was the decrease in bisecting N-acetylglucosamine (GlcNAc) in severe patients from all three cohorts. IgG galactosylation was also lower in severe cases in all cohorts, but the difference in galactosylation was not statistically significant after correction for multiple testing. To our knowledge, this is the first study exploring IgG N-glycome variability in COVID-19 severity.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Proteomic and metabolomic signatures associated with the immune response in healthy individuals immunized with an inactivated SARS-CoV-2 vaccine 93%
- Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues 93%
- Chronic hyperglycaemia drives functional impairment of lymphocytes in diabetic INSC94Y transgenic pigs 93%
Similar papers in this journal
- Towards middle-up analysis of polyclonal antibodies: subclass-specific N-glycosylation profiling of murine immunoglobulin G (IgG) by means of HPLC-MS 93%
- N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry 93%
- PapRIV, a BV-2 microglial cell activating quorum sensing peptide 92%
Similar papers in this journal
Similar papers in this journal
- Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19 95%
- Microarray-based detection of antibodies against SARS-CoV-2 proteins, common respiratory viruses and type I interferons 93%
- Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS-CoV-2 Spike protein after natural infection or COVID-19 vaccination 91%
Similar papers in this journal
- A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: effects on glycosylation and antigenicity 93%
- Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome 93%
- Post-translational modifications glycosylation and phosphorylation of the major hepatic plasma protein fetuin-A are associated with severity of CNS inflammation in children 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.